 |
인쇄하기
취소
|
Xenical granted additional indication for treatment of obesity in Korea's children and adolescents
Roche Korea's anti-obesity agent, Xenical (orlistat) has bee granted Korea's weight-loss drug for the treatment of obesity in children and adolescents. There are currently no products on the market for the treatment of child obesity, the company notes.
A recent study involving 539 obese children and adolescents (aged between 12 and 16 years) for 54 weeks showed that 27% of patients receivin...
A recent study involving 539 obese children and adolescents (aged between 12 and 16 years) for 54 weeks showed that 27% of patients receivin...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.